Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yuka Ikenoue"'
Publikováno v:
Medical Research Archives. 10
Background: Some foods can exacerbate the symptoms of irritable bowel syndrome (IBS), although the associations between the pathophysiology of IBS and IgG food antibodies levels are not well known. We examined IgG antibodies elicited in response to f
Autor:
Toyomi Ishibashi, Ryoichi Yoshihara, Toshifumi Hibi, Akiko Nihei, Yuka Ikenoue, Taku Kobayashi
Publikováno v:
Inflamm Intest Dis
Background and Aim: The prevalence of ulcerative colitis has increased in Asian populations in recent years. This Japanese internet survey investigated the symptoms, impact, and treatment of ulcerative colitis, and communication between patients and
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 24(4)
The elemental diet (ED) Elental® reportedly reduces adverse reactions to chemotherapy in digestive system cancer patients; however, the mechanism is unclear. Therefore, we verified the protective effect of ED against gastrointestinal disorders induc
Autor:
Yasuyo Suga, Manabu Suzuki, Keiko Saito, Takayuki Kajiura, Kaori Oomura, Masaki Hashimoto, Akira Mitsui, Junko Shinozaki, Maiko Mori, Yuka Ikenoue, Keiko Danjo, Masakazu Takazoe, Takaaki Kawaguchi, Naoki Yoshimura, Michihide Uo, Minako Sako
Publikováno v:
Journal of Gastroenterology
Background In Crohn’s disease (CD), the involvement of food antigens in immune responses remains unclear. The objective of this study was to detect immune responses against food antigens in CD patients and examine the mechanism in a mouse model of
Autor:
Yuka Ikenoue, Hiroto Miwa, Takayuki Matsumoto, Takashi Ohama, Masahiko Fujisawa, Yoshio Jinno, Hiroshi Ozaki, Masatoshi Hori, Masaharu Kiyosue, Takahisa Murata, Masaki Hashimoto
Publikováno v:
Journal of gastroenterology. 43(11)
Chronic intestinal inflammation is frequently accompanied by motility disorders. We previously reported that proinflammatory cytokines, such as tumor necrosis factor alpha and interleukin (IL)-1beta downregulate CPI-17, an endogenous inhibitor of ser
Publikováno v:
International immunopharmacology. 5(6)
A number of rodent models for inflammatory bowel disease (IBD) have been developed, but most cannot be used to develop and validate new therapies for IBD. From the models developed, the IL-10 deficient mouse model is the one that results in a disease